A Radiomics Model for Predicting the Response to Bevacizumab in Brain Necrosis after Radiotherapy
Clinical Cancer Research2020Vol. 26(20), pp. 5438–5447
Citations Over TimeTop 10% of 2020 papers
Jinhua Cai, Junjiong Zheng, Jun Shen, Zhiyong Yuan, Mingwei Xie, Miaomiao Gao, Hongqi Tan, Zhongguo Liang, Xiaoming Rong, Yi Li, Honghong Li, Jingru Jiang, Huiying Zhao, Andreas A. Argyriou, Melvin L.K. Chua, Yamei Tang
Abstract
The presented radiomics model, available as an online calculator, can serve as a user-friendly tool for individualized prediction of the response to bevacizumab in patients with brain necrosis after radiotherapy.
Related Papers
- → Bevacizumab 5 or 7.5 mg/kg in Metastatic Colorectal Cancer Can Be Infused Safely Over 10 Minutes(2011)5 cited
- → Two Cases of Emergency Operations in Patients Undergoing Bevacizumab Treatment(2010)3 cited
- → Two Cases of Leg Ulcer Caused by Bevacizumab(2017)1 cited
- → Bevacizumab Can Be Infused Safely Over 10 Minutes in Metastatic Colorectal Cancer(2014)
- Intracranial hemorrhage in patients treated with bevacizumab：Report of two cases(2011)